Please enlighten me as to why Pfizer would buy Leronlimab? They already own a CCR5 blocker and it was FDA approved back in 2007. Maraviroc is the name of the drug. Why would they compete with themselves by purchasing CYDY. Just of note, Pfizer never made any money on Maraviroc as an HIV medicine. Pfizer's drug is far from perfect having liver issues and strong side effect profile. However, I do not see them purchasing a second CCR5 inbibitor at least not one so similar to the one they already own.
Here is a simple description of all the CCR5 inhibitors. Too my knowledge only one, Maraviroc has FDA approval.
News 
Market Data 
Discover 
